- Home
- BPT vs CCEL Comparison
BPT vs CCEL Comparison
Compare BPT & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPT
- CCEL
- Stock Information
- Founded
- BPT 1989
- CCEL 1989
- Country
- BPT United States
- CCEL United States
- Employees
- BPT N/A
- CCEL N/A
- Industry
- BPT Integrated oil Companies
- CCEL Managed Health Care
- Sector
- BPT Energy
- CCEL Health Care
- Exchange
- BPT Nasdaq
- CCEL Nasdaq
- Market Cap
- BPT 49.2M
- CCEL 53.9M
- IPO Year
- BPT N/A
- CCEL 1997
- Fundamental
- Price
- BPT $1.25
- CCEL $5.81
- Analyst Decision
- BPT
- CCEL
- Analyst Count
- BPT 0
- CCEL 0
- Target Price
- BPT N/A
- CCEL N/A
- AVG Volume (30 Days)
- BPT 239.1K
- CCEL 3.5K
- Earning Date
- BPT 11-07-2024
- CCEL 10-22-2024
- Dividend Yield
- BPT N/A
- CCEL N/A
- EPS Growth
- BPT N/A
- CCEL N/A
- EPS
- BPT N/A
- CCEL N/A
- Revenue
- BPT $271,000.00
- CCEL $31,641,636.00
- Revenue This Year
- BPT N/A
- CCEL $3.70
- Revenue Next Year
- BPT N/A
- CCEL $10.57
- P/E Ratio
- BPT N/A
- CCEL N/A
- Revenue Growth
- BPT N/A
- CCEL 1.93
- 52 Week Low
- BPT $1.04
- CCEL $3.67
- 52 Week High
- BPT $5.86
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- BPT 48.49
- CCEL 40.77
- Support Level
- BPT $1.11
- CCEL $6.29
- Resistance Level
- BPT $1.40
- CCEL $6.80
- Average True Range (ATR)
- BPT 0.09
- CCEL 0.26
- MACD
- BPT 0.03
- CCEL -0.00
- Stochastic Oscillator
- BPT 72.22
- CCEL 0.00
About BPT BP Prudhoe Bay Royalty Trust
BP Prudhoe Bay Royalty Trust is a grantor trust operating in the US. The property of the Trust consists of an overriding royalty interest. The Royalty Interest entitles the Trust to receive the royalty from the production of crude oil and condensate from the working interest of BP Exploration (Alaska) Inc. in the Prudhoe Bay oil field located on the North Slope of Alaska.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.